REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Avancegen S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Avancegen S.A. Profile Updated: April 10, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Spanish Download a sample report

Avancegen S.A. is a company based in Ecuador, with its head office in Guayaquil. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The enterprise was incorporated on October 18, 2018. It currently has a total number of 10 (2022) employees. In 2022, the company reported a net sales revenue increase of 78.81%. Its’ total assets recorded a negative growth of 95.1%. The enterprise’s net profit margin decreased by 19.67% in 2022.

Headquarters
Colinas de los Ceibos Avenida Principal 103
Guayaquil; Guayas;

Contact Details: Purchase the Avancegen S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Avancegen S.A. report to view the information.
Outstanding Shares:
Purchase the Avancegen S.A. report to view the information.
Registered Capital:
Purchase the Avancegen S.A. report to view the information.
Incorporation Date:
October 18, 2018
Key Executives
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
99.88%
Purchase this report to view the information.
0.12%
Company Performance
Financial values in the chart are available after Avancegen S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
78.81%▲
Total operating revenue
78.81%▲
Operating profit (EBIT)
-23324.21%▼
Net Profit (Loss) for the Period
-13054.37%▼
Total assets
-95.1%▼
Total equity
N/A
Operating Profit Margin (ROS)
-35.23%▼
Net Profit Margin
-19.67%▼
Return on Equity (ROE)
N/A
Quick Ratio
-0.14%▼
Cash Ratio
-0.03%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo